JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hepburn, M. J.
Right arrow Articles by Kuhn, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hepburn, M. J.
Right arrow Articles by Kuhn, C. M.

Vol. 281, Issue 3, 1350-1356, 1997

Differential Effects of Naltrindole on Morphine-Induced Tolerance and Physical Dependence in Rats1

Matthew J. Hepburn, Patrick J. Little, Jeanine Gingras and Cynthia M. Kuhn

Departments of Pharmacology (M.J.H., P.J.L., C.M.K.) and Pediatrics (J.G.), Duke University Medical Center, Durham, North Carolina

This study investigated the effect of delta opioid receptor blockade by naltrindole on the development of physical dependence and tolerance to the antinociceptive and respiratory depressive effects of morphine in rats. Chronic morphine was delivered either by s.c. injection of increasing amounts of morphine over 5 days or by s.c. implantation of morphine pellets. Animals were cotreated with saline or naltrindole. Antinociception and respiratory depression were assessed after administration of a challenge dose of morphine, and withdrawal signs were determined after naloxone challenge. Naltrindole significantly attenuated the development of antinociceptive tolerance after all three chronic treatment regimens. In addition, rats pretreated with naltrindole displayed significantly fewer withdrawal symptoms and less weight loss after a naloxone challenge. In contrast, naltrindole did not prevent the development of tolerance to morphine-induced respiratory depression. These results imply that tolerance to antinociception and physical dependence involves adaptations at interacting mu and delta receptor populations, whereas tolerance to respiratory depression reflects actions of independent mu and delta receptor populations. These findings suggest that delta antagonists may have potential clinical application for decreasing the rapid development of tolerance to opiate-induced analgesia, while allowing for the development of protective tolerance to respiratory depression.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
P. A. Claude-Geppert, J. Liu, J. Solberg, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law
Antagonist Efficacy in MORS196L Mutant Is Affected by the Interaction between Transmembrane Domains of the Opioid Receptor
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 216 - 226.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Roy, X. Guo, J. Kelschenbach, Y. Liu, and H. H. Loh
In Vivo Activation of a Mutant {micro}-Opioid Receptor by Naltrexone Produces a Potent Analgesic Effect But No Tolerance: Role of {micro}-Receptor Activation and {delta}-Receptor Blockade in Morphine Tolerance
J. Neurosci., March 23, 2005; 25(12): 3229 - 3233.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Morinville, C. M. Cahill, M. J. Esdaile, H. Aibak, B. Collier, B. L. Kieffer, and A. Beaudet
Regulation of {delta}-Opioid Receptor Trafficking via {micro}-Opioid Receptor Stimulation: Evidence from {micro}-Opioid Receptor Knock-Out Mice
J. Neurosci., June 15, 2003; 23(12): 4888 - 4898.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P.-Y. Law, J. W. Yang, X. Guo, and H. H. Loh
In vivo activation of a mutant {micro}-opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects
PNAS, February 18, 2003; 100(4): 2117 - 2121.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. J. Martin, S. A. Kim, D. G. Cannon, G. M. Sizemore, D. Bian, F. Porreca, and J. E. Smith
Antagonism of delta 2-Opioid Receptors by Naltrindole-5'-isothiocyanate Attenuates Heroin Self-Administration but Not Antinociception in Rats
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 975 - 982.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.